What is Clinical Research Optimized™?
Biorasi is not just a contract research organization. We are a new kind of CRO, dedicated to delivering Clinical Research Optimized™ for our sponsors. We believe that the contract research organization industry is failing sponsors, and we strive achieve the ideal balance of cost, time and risk for our sponsors in every trial . Through innovative processes and technologies, dedication to sponsors, and a culture of ownership, our team will deliver your trial on time and on budget, every time.
KEEP YOUR CLINICAL TRIALS ON TARGET
Biorasi is recognized as a leading expert in delivering success where other CROs fail.
We are a trial rescue expert, recognized for our ability to complete trials that much larger CROs falter on. In our 15 years of experience, we’ve been able to rescue clinical trials from some of the leading names in pharma, lead by some of the most prominent contract research organizations in the world. Our rescue expertise doesn’t just save our sponsors time and money – it saves entire drug development programs.
"One of the rarest events, where we had to communicate [to Biorasi] to stop the screening rather than boost it."VP of Global Clinical Development, Top Specialty Pharma
With a global market of USD 3.3 billion during 2016 and a forecast surpassing USD 10.5 billion by 2023, Biosimilars have received more than their fair share of hype in the pharma world due to the undeniable value they bring to the healthcare system in terms of...read more
Immunoglobulin A (IgA) is an antibody manufactured by the body’s immune system to protect against invaders. Immunoglobulin A nephropathy (IgAN) is a common kidney disease where too much IgA is deposited into the kidneys causing severe inflammation and damage to the...read more
Despite an extremely encouraging 38% decrease in mortality since 1989, Breast Cancer remains the most common type of cancer in the US. Indeed, it is estimated that in 2017, there will be 252,710 new cases of invasive breast cancer and over 40,000 breast cancer deaths...read more
Approximately 60,000 Americans are diagnosed with Parkinson's disease each year, and more than 10 million people worldwide are living with Parkinson's disease (PD). With no predictive lab test or cure, PD is proving to be a very debilitating, chronic and costly...read more
According to the CDC, post-traumatic stress disorder (PTSD) is one of the most common mental disorders present in the general population. In the United States an estimated 8% of the population, over 24 million people are affected, costing the U.S. healthcare system...read more
Clinical research in dermatology has a reputation for being simple and easy to conduct compared to other therapeutic areas. Developing therapies for the largest organ in the human body is not an easy task. For starters, dermatological conditions represent one of the...read more